Use of Immune Checkpoint Inhibitors in End Stage Kidney Disease Patients, Single Center Experience and Review of the Literature

Kidney360. 2020 Mar 18;1(5):399-402. doi: 10.34067/KID.0000422020. eCollection 2020 May 28.
No abstract available

Keywords: checkpoint inhibitors; dialysis; immunotherapy; nivolumab; onconephrology; pembrolizumab.

Publication types

  • Review

MeSH terms

  • Carcinoma, Renal Cell* / chemically induced
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Kidney Failure, Chronic* / drug therapy
  • Kidney Neoplasms* / drug therapy
  • Nivolumab / therapeutic use

Substances

  • Immune Checkpoint Inhibitors
  • Nivolumab